Merck executes its own Brexit, moving all R&D operations out of UK | Fierce Biotech

​  Less than two years after breaking ground on a ballyhooed £1 billion R&D center and future UK headquarters, Merck is scrapping the project. Read More 

Share the news

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.